This result is further supported by the characteristic high Ki67 expression of intratumoral CD39+ Tpex cells in the HNSCC dataset, which includes 6 out of 8 samples post-ICB therapy (Figs. S3B, S3C, S3D). The gene discussed is ENTPD1; the disease is head and neck squamous cell carcinoma.